198 related articles for article (PubMed ID: 23157520)
1. Conflict of interest: will it ever end?
Carney SL
Intern Med J; 2012 Nov; 42(11):1255-6. PubMed ID: 23157520
[TBL] [Abstract][Full Text] [Related]
2. The statin wars.
McKillop T
Lancet; 2003 Nov; 362(9394):1498. PubMed ID: 14602449
[No Abstract] [Full Text] [Related]
3. Public health. U.S. panel favors wider use of preventive drug treatment.
Couzin-Frankel J
Science; 2010 Jan; 327(5962):130-1. PubMed ID: 20056859
[No Abstract] [Full Text] [Related]
4. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
[No Abstract] [Full Text] [Related]
5. The numbers are in: statins for the primary prevention of cardiovascular disease in women.
Duvernoy CS; Blumenthal R
Circulation; 2010 Mar; 121(9):1063-5. PubMed ID: 20176993
[No Abstract] [Full Text] [Related]
6. The stain wars.
Olsson GO; Blasetto JW; Bryzinski BS; Caplan RJ; Gold A
Lancet; 2003 Nov; 362(9398):1855-6; discussion 1856. PubMed ID: 14654329
[No Abstract] [Full Text] [Related]
7. Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.
Cardiovasc J Afr; 2008; 19(2):117. PubMed ID: 18516361
[No Abstract] [Full Text] [Related]
8. Cardiovascular risk in uremic patients: darkness after AURORA.
Robles NR; Macias JF
Ren Fail; 2010 Jan; 32(2):269-72. PubMed ID: 20199190
[No Abstract] [Full Text] [Related]
9. Rosuvastatin in patients with elevated C-reactive protein.
Mak KH; Chan ES
N Engl J Med; 2009 Mar; 360(10):1039-40; author reply 1041-2. PubMed ID: 19271274
[No Abstract] [Full Text] [Related]
10. The stain wars.
Jureidini J; Mansfield P; Menkes D
Lancet; 2003 Nov; 362(9398):1855; discussion 1856. PubMed ID: 14654332
[No Abstract] [Full Text] [Related]
11. [By JUPITER! Disease mongering!].
Welin L; Peterson M
Lakartidningen; 2008 Dec; 105(51-52):3756; discussion 3756-7. PubMed ID: 19278103
[No Abstract] [Full Text] [Related]
12. Using Crestor--and all statins--safely. Some simple steps can help minimize or avoid muscle problems from these cholesterol-lowering drugs.
Harv Heart Lett; 2005 Sep; 16(1):3. PubMed ID: 16211723
[No Abstract] [Full Text] [Related]
13. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.
Ann Intern Med; 2010 Apr; 152(8):I34. PubMed ID: 20404365
[No Abstract] [Full Text] [Related]
14. New drug to lower cholesterol.
FDA Consum; 2003; 37(6):3. PubMed ID: 14983802
[No Abstract] [Full Text] [Related]
15. [Statin cuts cardiovascular risk in half].
Einecke D
MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
[No Abstract] [Full Text] [Related]
16. Atorvastatin for stroke prevention.
Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
[No Abstract] [Full Text] [Related]
17. Two more drugs for dyslipidemia.
Roberts WC
Am J Cardiol; 2004 Mar; 93(6):809-11. PubMed ID: 15019903
[No Abstract] [Full Text] [Related]
18. Rosuvastatin in patients with elevated C-reactive protein.
Gibbons RJ
N Engl J Med; 2009 Mar; 360(10):1038; author reply 1041-2. PubMed ID: 19264695
[No Abstract] [Full Text] [Related]
19. Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".
Wells MT; Eisenberg T
Circulation; 2010 Dec; 122(23):e575; author reply e577. PubMed ID: 21135368
[No Abstract] [Full Text] [Related]
20. Letter by Vos et al regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials".
Vos E; Rose CP; Biron P
Circulation; 2010 Dec; 122(23):e576; author reply e577. PubMed ID: 21135369
[No Abstract] [Full Text] [Related]
[Next] [New Search]
